Alejandro Gomezochoa
FDA import alert and refusal historyTlayacapan, MexicoFEI 3010652246
As of October 26, 2026, Alejandro Gomezochoa (Tlayacapan, Mexico) is on the red list of FDA Import Alert 99-05 (Raw agricultural products: pesticides) for nopales; cactus, published by FDA on March 25, 2014, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-05 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Alejandro Gomezochoa
1 record, newest first. Each line links to the FDA page it came from.
2014
- Import alert listingListed on Import Alert 99-05red listNopales; CactusSource
Questions about Alejandro Gomezochoa
- Is Alejandro Gomezochoa on an FDA import alert?
- Yes. As of October 26, 2026, Alejandro Gomezochoa is on the red list of FDA Import Alert 99-05, “Raw agricultural products: pesticides”, for nopales; cactus; FDA published the listing on March 25, 2014.
- Has FDA refused shipments from Alejandro Gomezochoa?
- No FDA import refusals for Alejandro Gomezochoa appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Alejandro Gomezochoa's FEI number?
- Alejandro Gomezochoa's FDA Establishment Identifier (FEI) is 3010652246.
- Can shipments from Alejandro Gomezochoa still enter the U.S.?
- Shipments of nopales; cactus from Alejandro Gomezochoa can be detained without physical examination under Import Alert 99-05; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Alejandro Gomezochoa?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.